Chung S, Sonntag KC, Andersson T, Bjorklund LM, Park JJ, Kim DW, et al. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur. J. Neurosci. 2002;16:1829-38.

Maurice T, Lockhart BP, Privat A. Amnesia induced in mice by centrally administered betaamyloid peptides involves cholinergic dysfunction. Brain Res. 1996;706(2):181-93.

Ramsden M, Henderson Z, Pearson H. Modulation of Ca2+ channel currents in primary cultures of rat cortical neurones by amyloid beta protein(1-40) is dependent on solubility status. Brain Res. 2002;956:254-61.

Kitagawa K, Matsumoto M, Niinobe M, Mikoshiba K, Hata R, Ueda H, et al. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage- immunohistochemical investigation of dendritic damage. Neuroscience. 1989;31(2):401-11.

Mattson MP, Rydel RE, Lieberburg I, Smith- Swintosky VL. Altered calcium signaling and neuronal injury: stroke and Alzheimer’s disease as examples. Ann. N. Y. Acad. Sci. 1993;28:1-21.

Saito K, Elce JS, Hamos JE, Nixon RA. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer [sic] disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U S A. 1993;90(7):2628-32.

McKee AC, Kowall NW, Kosik KS. Microtubular reorganization and dendritic growth response in Alzheimer’s disease. Ann. Neurol. 1989;26(5):652-9.

Goedert M, Spillantini MG, Potier MC, Ulrich j, Crowther RA. Cloning and sequencing of the cDNA encoding an isoform of microtubuleassociated protein Tau containing four tandem repeats: differential expression of Tau protein mRNAs in human brain. EMBO J. 1989;8(2):393-9.

Weingartner H. Models of memory dysfunctions. Ann. N. Y. Acad. Sci. 1985;444:359-69.

Cleveland DW, Hwo SY, Kirschner MW. Physical and chemical properties of purified Tau factor and the role of Tau in microtubule assembly. J. Mol. Biol. 1977;116(2):227-47.

Miranda S, Opazo C, Larrondo LF, Munoz FJ, Ruiz F, Leighton F, et al. The role of oxidative stress in the toxicity induced by amyloid betapeptide in Alzheimer’s disease. Prog. Neurobiol. 2000;62(6):633-48.

Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 1993;13(4):1676-87.

Weldon DT, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O’Hare E, et al. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 1998;18(6):2161-73.

Forloni G, Del Bo R, Angeretti N, Smiroldo S, Gabellini N, Vantini G. Nerve growth factor does not influence the expression of beta amyloid precursor protein mRNA in rat brain: in vivo and in vitro studies. Brain Res. 1993;620(2):292-6.

Shen YX, Wei W, Yang J, Liu C. Improvement of melatonin on learning and memory impairment induced by amyloid betapeptide 25-35 in elder rats. Acta. Pharmacol. Sin. 2001;22:797-803.

Hu ZH, Wang XC, Li LY, Liu ML, Liu R, Ling Z, et al. Correlation of behavior changes and BOLD signal in Alzheimer-like [sic] rat model. Acta. Biochim. Biophys. Sin (Shanghai). 2004;36(12):803-10.

Teng J, Takei Y, Harada A, Nakata T, Chen J, Hirokawa N. Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization. J. Cell. Biol. 2001;155(1):65-76.

Bernhardt R, Matus A. Light and electron microscopic studies of the distribution of microtubuleassociated protein 2 in rat brain: a difference between dendritic and axonal cytoskeletons. J. Comp. Neurol. 1984;226(2):203-21.

Araki T, Kato H, Fujiwara T, Kogure K, Itoyama Y. Post-ischemic changes of [3H]glycine binding in the gerbil brain after cerebral ischemia. Eur. J. Pharmacol. 1995;278(2):91-6.

Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184-5.

Kidd M. Paired helical filaments in electron microscopy of Alzheimer’s disease. Nature. 1963;197:192-3.

Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ. Subtypes and differential laminar distributions of beta A4 deposits in Alzheimer’s disease: relationship with the intellectual status of 26 cases. Acta. Neuropathol. 1991;81(3):328-35.

Barghorn S, Davies P, Mandelkow E. Tau paired helical filaments from Alzheimer’s disease brain and assembled in vitro are based on β-structure in the core domain. Biochemistry. 2004;43:1694-1703.

Flament S, Delacourte A, Delaere P, Duyckaerts C, Hauw JJ. Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration. Acta. Neuropathol. 1990;80(2):212-5.

Holzer M, Holzapfel HP, Zedlick D, Bruckner MK, Arendt T. Abnormally phosphorylated Tau protein in Alzheimer’s disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience. 1994;63(2):499-516.

Oddo S, Caccamo A, Green KN, Liang K, Tran L, Chen Y, et al. Chronic nicotine administration exacerbates Tau pathology in a transgenic model of Alzheimer’s disease. Proc. Natl. Acad. Sci. U S A. 2005;102(8):3046-51.